The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...
VS-105 is under development for the treatment of osteoporosis, secondary hyperparathyroidism in chronic kidney disease, inflammatory bowel disease, psoriasis. It is administered through oral route. VS ...
NaQuinate is under clinical development by Haoma Medica and currently in Phase I for Osteoporosis. According to GlobalData, Phase I drugs for Osteoporosis have a 65% phase transition success rate ...
Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...